Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Axitinib treatment turned a man's grey hair back to black.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Using tretinoin and hydroquinone can speed up the fading of skin pigmentation.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Tangent screens help detect visual field defects from vigabatrin.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

A woman developed folliculitis after taking acitretin for psoriasis, which was treated with skin dressing and antibiotics.

Fzd2 is important for skin and hair development through various signaling ways.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Ritlecitinib can help about 14,000 people with severe hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

NB-UVB phototherapy is an effective and safe treatment for vitiligo, especially on hands and feet, and can be improved with tacrolimus.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.